ABR-238901
Selleck Chemicals
SKU:E1134-5MG
Couldn't load pickup availability
ABR-238901 is an inhibitor of TLR used in studies of Immune Signaling. In practice, this places the compound in experiments that measure cytokine-mediated signaling and inflammatory effector responses in immunology and inflammation models.
By inhibiting TLR, ABR-238901 can be used to examine cytokine-mediated signaling and inflammatory effector responses. The immunomodulator annotation adds relevance to immune-cell activation, cytokine, and mediator assays, together with downstream-response mapping in the same experimental setting. In immunology and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving TLR
- Pathway perturbation studies connected to Immune Signaling
- Concentration-response inhibition and target-dependence studies
- Immune-cell activation, cytokine, and mediator assays
Overall, ABR-238901 is appropriate when a defined chemical perturbant is needed to connect TLR with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in immunology and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- TLR
- Target Class:
- Immunomodulator
- Pathways:
- Immune Signaling
- Research Area:
- Immunology • Inflammation
- CAS No.:
- 1638200-22-2
- Molecular Weight:
- 394.63
- Formula:
- C₁₁H₉BrClN₃O₄S
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.